Day 1 | September 16

SEPTEMBER 16
SPONSOR SEMINARS
CHAIRS: Diego Centonze & Roberto Furlan
MERCK
11:00-12:00: Merck heritage and commitment in the new MS era: past, present and future Andrea Paolillo (Merck)

AINI MEETS NOVARTIS
12:00-12:45: Novartis research in Neuroimmunology Marc Bigaud (Novartis)

13:00-14:00 LUNCH BREAK

BIOGEN
14:00-14:45: Next generation research: creating value through pioneering science Chris Henderson (Head of Research, Biogen)

ALEXION
14:45-15:45: Complement inhibition in rare neurological immune-mediated diseases-Alexion's reach programs Gianluca Pirozzi (Alexion Pharmaceuticals Inc)

ROCHE
15:45-16:45 L'impegno di Roche nelle neuroscienze: dagli anticorpi monoclonali alle piattaforme digitali Anna Maria Porrini (Direttore medico di Roche Italia)
XXIX AINI CONGRESS
WELCOME ADDRESS
16:45-17:00: Gabriela Constantin & Roberta Magliozzi & Bruno Bonetti (University of Verona, Italy)
OPENING SESSION: NEW IMMUNE AND INFLAMMATORY MECHANISMS IN BRAIN DISEASES I
CHAIRS: Gabriela Constantin & Bruno Bonetti
LECTURE I
17:00-17:45: Innate immunity and inflammation: double-edge swords Alberto Mantovani (Humanitas University Milan, Italy)

LECTURE II
17:45-18:30: β-Synuclein-reactive T cells in autoimmune CNS grey matter degeneration Alexander Flügel (University Medical Center Göttingen, Germany)

ORAL PRESENTATIONS
18:30-18:50: Role of SLC7A11 in the control of Treg cell homeostasis in autoimmunity Claudio Procaccini (Laboratorio di Immunologia, Istituto per l’Endocrinologia e l’Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), 80131 Napoli, Italy)
18:50-19:10: Macrophage dynamics at the borders of the central nervous system Giuseppe Locatelli (University of Bern, Switzerland)
19:10-19:30: γδ T cells play a role in the pathogenesis of Alzheimer’s disease Anna Slanzi (University of Verona, Italy)

19:30 Welcome Cocktail